Last reviewed · How we verify
NCT07385443: DM1-Hub
The Spanish National Registry for Myotonic Dystrophy Type 1
trial testing Patient Registry in Myotonic Dystrophy 1 in 3,000 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Fundació Institut Germans Trias i Pujol |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 3,000 |
| Start date | 2 June 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 8 locations across Spain |
Drugs / interventions tested
- Patient Registry
Conditions studied
- Myotonic Dystrophy 1 — all drugs for Myotonic Dystrophy 1 →
- DM1 — all drugs for DM1 →
- Myotonic Dystrophy Type 1 — all drugs for Myotonic Dystrophy Type 1 →
- Myotonic Dystrophy, Congenital — all drugs for Myotonic Dystrophy, Congenital →
Sponsor
Fundació Institut Germans Trias i Pujol — full company profile →
Who can join
Eligibility, any sex, with Myotonic Dystrophy 1 or DM1. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Myotonic Dystrophy Type 1 (DM1) is a rare genetic neuromuscular condition that can affect multiple organs and varies widely in how it presents. DM1 is the most common form of adult-onset muscular dystrophy, with an estimated prevalence of approximately 1-5 per 10,000 people. In Spain, the condition shows notable regional differences, making it especially important to understand its characteristics within the population. The aim of this study is to support a research initiative designed to better characterise DM1. We are developing a comprehensive national registry, collecting patient-reported information, clinical data and omics data that will improve our understanding of the disease and help identify individuals who may be eligible for clinical trials.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07385443
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Patient Registry
Trials testing the same drug.
- NCT05848271 — Natural History Study of Patients with HPDL Mutations · recruiting
- NCT04292574 — UK SMA Patient Registry · recruiting
Other recruiting trials for Myotonic Dystrophy 1
Currently open trials in the same condition.
- NCT06378216 — Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe] · recruiting
- NCT03981575 — Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) · recruiting
Other Fundació Institut Germans Trias i Pujol trials
Trials by the same sponsor.
- NCT05780073 — Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment · Phase 2 · completed
- NCT06149754 — BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy · unknown
- NCT05752643 — Feasibility and Impact of Online HIV/STI Screening Addressed to PrEP Users in Spain · NA · unknown
- NCT06706596 — A Systemic Screening for TB Disease in High-risk Groups in Barcelona · recruiting
- NCT04751669 — Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07385443 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació Institut Germans Trias i Pujol
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07385443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing